Current Topics in Bioinformatics 2026: AI in Molecular Medicine
Artificial intelligence is rapidly reshaping molecular medicine — from genomics and biomarker discovery to drug development and precision treatment.
This event brings together leading voices from academia and industry to explore how these advances are translating into real-world impact. The focus is on substantive exchange across research, application, and future direction, with a strong emphasis on collaboration between institutions and industry partners.
The event is co-organized by Humboldt University, the Max Delbrück Center, the Max Planck Institute for Molecular Genetics, Merantix Momentum, and Cluster HealthCapital.
What to expect
Across a series of expert inputs and discussions, we will explore:
Current advances in AI-driven molecular medicine across research and industry
How AI is accelerating genomics, biomarker discovery, toxicology, and drug development
New approaches in single-cell analysis and spatial biology
How AI is enabling precision medicine and clinical translation
Key challenges in moving from research breakthroughs to real-world deployment
At this year’s bioinformatics meeting we will further explore how artificial intelligence is transforming molecular medicine by enabling the analysis of complex biological data, including applications in disease prediction and AI-driven drug development. The goal is to foster interdisciplinary dialogue between researchers, clinicians, and data scientists, and to provide a forward-looking perspective on the role of AI in shaping the future of molecular medicine.
Program
2:00 pm — Registration open
2:30 pm — Welcome
2:45 pm — AI in Medicine Today and Tomorrow
Alexander Meyer, Charité – Institute for Artificial Medicine
3:30 pm — From Data Silos to Insights: PRINCE – A Multi-Agent AI System for Toxicology and Preclinical Drug Development
Annika Kreuchwig & Jonas Muench, Bayer AG
4:00 pm — Coffee Break
4:30 pm — Search the world’s single-cell data in seconds
Nikos Karaiskos & Daniel Perinán, MDC-BIMSB
5:00 pm — Building biologically informed AI for genomics and virtual cell simulations
Ekin Deniz Aksu, Max Planck Institute for Molecular Genetics
5:20 pm — HLA peptide characterisation and off-target toxicity with applied AI
Alisa Fuchs, Alithea Biotechnology GmbH
5:35 pm — N.N.
5:50 pm — Wrap-up & concluding remarks
6:00 pm — Get together (until 7:00 pm)
Speakers & perspectives
The program brings together contributions from:
Charité – Universitätsmedizin Berlin
Berlin Institute for Medical Systems Biology
Bayer
Max Planck Institute for Molecular Genetics
Humboldt University and partner institutes
This creates a unique intersection of academic research leadership and applied life sciences innovation within the Berlin bioinformatics ecosystem.
Who should attend
Researchers in bioinformatics, genomics, and AI
Professionals in pharma, biotech, and life sciences
Leaders working at the intersection of AI, medicine, and data-driven healthcare
Atmosphere
This is a research-driven community event focused on meaningful exchange between science and industry. The goal is to connect perspectives, share challenges, and discuss how AI is actually changing molecular medicine in practice. Coffee, refreshments, and drinks will be provided throughout.